GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (OTCPK:MEPTF) » Definitions » 3-Year Revenue Growth Rate

Medipost Co (Medipost Co) 3-Year Revenue Growth Rate : -9.30% (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Medipost Co 3-Year Revenue Growth Rate?

Medipost Co's Revenue per Share for the three months ended in Mar. 2024 was $1.75.

During the past 12 months, Medipost Co's average Revenue per Share Growth Rate was -13.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was -9.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 8.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was 1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Medipost Co was 42.70% per year. The lowest was -17.30% per year. And the median was 4.95% per year.


Competitive Comparison of Medipost Co's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Medipost Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipost Co's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medipost Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Medipost Co's 3-Year Revenue Growth Rate falls into.



Medipost Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Medipost Co  (OTCPK:MEPTF) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Medipost Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Medipost Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Medipost Co (Medipost Co) Business Description

Traded in Other Exchanges
Address
21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR
Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (Medipost Co) Headlines

No Headlines